Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Shares Issued (2020 - 2025)

Apellis Pharmaceuticals (APLS) has 6 years of Shares Issued data on record, last reported at $100000.0 in Q4 2025.

  • For Q4 2025, Shares Issued fell 99.1% year-over-year to $100000.0; the TTM value through Dec 2025 reached $5.5 million, down 61.27%, while the annual FY2025 figure was $5.5 million, 61.27% down from the prior year.
  • Shares Issued reached $100000.0 in Q4 2025 per APLS's latest filing, down from $797000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $380.1 million in Q1 2022 and bottomed at -$377.6 million in Q2 2022.
  • Average Shares Issued over 5 years is $21.4 million, with a median of $2.5 million recorded in 2021.
  • The widest YoY moves for Shares Issued: up 15119.23% in 2022, down 5446.77% in 2022.
  • A 5-year view of Shares Issued shows it stood at $368.2 million in 2021, then plummeted by 197.39% to -$358.6 million in 2022, then surged by 100.45% to $1.6 million in 2023, then skyrocketed by 584.91% to $11.1 million in 2024, then tumbled by 99.1% to $100000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $100000.0 in Q4 2025, $797000.0 in Q3 2025, and $4.4 million in Q2 2025.